3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Prostatic Neoplasms
3
Meningioma
3
Brain Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
2
Sarcoma
2
Radiation Injuries
2
Pituitary Neoplasms
2
Nerve Sheath Neoplasms
2
Neoplasms
2
Head and Neck Neoplasms
2
Esophageal Neoplasms
2
Wilms Tumor
1
Vascular Neoplasms
1
Uterine Cervical Neoplasms
1
Thymus Neoplasms
1
Thymoma
1
Solitary Fibrous Tumors
1
Smooth Muscle Tumor
1
Sarcoma, Clear Cell
1
Resectable Lung Non-Small Cell Carcinoma
1
Pancreatic Neoplasms
1
Osteosarcoma
1
Oropharyngeal Neoplasms
1
Neurofibrosarcoma
1
Neuroblastoma
1
Neurilemmoma
1
Neoplasms, Adipose Tissue
1
Nasopharyngeal Carcinoma
1
Myoepithelioma
1
Mesothelioma, Malignant
1
Interventions
Echocardiography
4
Electrocardiography
2
sulforaphane
1
schizandrin
1
sacubitril and valsartan sodium hydrate drug combination
1
pegfilgrastim
1
nicotinamide-beta-riboside
1
fructus schizandrae, radix ginseng, radix ophiopogonis drug combination
1
empagliflozin
1
Watchful Waiting
1
Vincristine
1
Tablets
1
Rituximab
1
Proton Therapy
1
Proteins
1
Prednisolone
1
Observation
1
Medical History Taking
1
Lenalidomide
1
Laser-Doppler Flowmetry
1
Exercise
1
Environmental Biomarkers
1
Echocardiography, Stress
1
Doxorubicin
1
Dexrazoxane
1
Cyclophosphamide
1
Clinical Laboratory Techniques
1
Chemoradiotherapy
1
Carvedilol
1
Blood Pressure Determination
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Cardiotoxicity
×
Proton Therapy
×
Clear all
NCT04822077
2021-03-30
PROTHYM
Swedish Lung Cancer Study Group
Phase NA
Recruiting
40 enrolled